A Study of the VISION5 Product in Patients With Glaucoma or Ocular Hypertension

Clinical trial NCT01943721 · COMPLETED

Trial details

NCT number: NCT01943721
Sponsor: ForSight Vision5, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Ocular Hypertension Primary Open Angle Glaucoma

Start date: 2013-10-01
Primary completion: 2014-06-01
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.